---
title: "Tellgen's shareholder Rongzhen Investment plans to reduce its holdings by no more than 0.71%"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/242763490.md"
description: "According to the Zhitong Finance APP, Tellgen announced that its shareholder Shanghai Rongzhen Investment Group Co., Ltd. (\"Rongzhen Investment\") will reduce its holdings of the company's shares by no more than 1.15 million shares (accounting for 0.71% of the company's total share capital) through centralized bidding on the stock exchange or block trading within three months after the disclosure of this announcement, starting from three trading days after the announcement"
datetime: "2025-06-02T08:55:03.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/242763490.md)
  - [en](https://longbridge.com/en/news/242763490.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/242763490.md)
generator: "portal-rs"
---

# Tellgen's shareholder Rongzhen Investment plans to reduce its holdings by no more than 0.71%

According to the announcement from Zhitong Finance APP, Tellgen (300642.SZ) announced that its shareholder Shanghai Rongzhen Investment Group Co., Ltd. ("Rongzhen Investment") will reduce its holdings of the company's shares by no more than 1.15 million shares (accounting for 0.71% of the company's total share capital) through centralized bidding on the stock exchange or block trading within three months after the disclosure of this announcement, starting from three trading days after the announcement

### Related Stocks

- [300642.CN](https://longbridge.com/en/quote/300642.CN.md)

## Related News & Research

- [SalMar – Record-strong biological performance](https://longbridge.com/en/news/296859687.md)
- [Frozen blueberries recall categorized under FDA's highest Class I risk level](https://longbridge.com/en/news/296506599.md)
- [13:49 ETVascarta Outlines Proposed Mechanistic Link Between VAS-101's (Vasceptor®) Vascular and Red Blood Cell Effects in Sickle Cell Disease](https://longbridge.com/en/news/296524035.md)
- [09:02 ETEvolved By Nature's Peptide Platform Used in FDA-Cleared Prescription Therapy for the Management of Atopic Dermatitis](https://longbridge.com/en/news/296496101.md)
- [09:03 ETPTS Group Launches PTS Medical, Expanding the Brokerage Platform Into New Healthcare Verticals](https://longbridge.com/en/news/296496412.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**